Cintirorgon

CAS No. 2055536-64-4

Cintirorgon( LYC-55716 )

Catalog No. M23919 CAS No. 2055536-64-4

Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 135 In Stock
10MG 186 In Stock
25MG 312 In Stock
50MG 464 In Stock
100MG 672 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cintirorgon
  • Note
    Research use only, not for human use.
  • Brief Description
    Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
  • Description
    Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    LYC-55716
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    RORγ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2055536-64-4
  • Formula Weight
    603.53
  • Molecular Formula
    C27H23F6NO6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:110 mg/mL (182.26 mM)
  • SMILES
    CC(C)(C[C@H]1CN(C2=C(O1)C=CC(=C2)C3=CC(=CC(=C3)F)OC(F)F)S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lycera Announces Initiation of Phase 1/2a Study ARGON of Immuno-Oncology Candidate LYC-55716 in Patients with Advanced Solid Tumors. Jan 04, 2017.
molnova catalog
related products
  • BDP9066

    BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.

  • ROCK inhibitor-2

    ROCK inhibitor-2 is a selective dual inhibitor of ROCK1 and ROCK2 (IC50s of 17 nM and 2 nM, respectively).

  • CLINODISIDE A

    Clinodiside A in rats with one compartment open model into the body, rapid distribution, elimination rate.